Shareo.

PME · buy

Called by Equity Mates Investing Podcast on 2026-07-01 · horizon: long-term

“if this isn't a ringing endorsement for subscribing to Equity Mates wherever you're watching or listening, because we've been talking about Pro Medicus for a lot of this year being like, AI is not gonna disrupt Pro Medicus. Like, it's so trusted, it's ingrained, it's regulatory approval. Like, all of those things can't be vibe coded away.”
HorizonReturnAlpha vs benchmarkHit?As of
30d-19.57%-22.52% 2026-07-31

Risk: max drawdown 25.2% · volatility 42.7% ann. · Sharpe-proxy -6.21